Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty

Ting Chao Lin, Chun Yang Huang, Po Lin Chen, Chiu Yang Lee, Chun Che Shih, I. Ming Chen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: To report a retrospective analysis of risk factors for edge restenosis after Viabahn stent-graft treatment of superficial femoral artery (SFA) occlusive disease and determine any protective effect of drug-coated balloons (DCBs) used at the time of stent-graft implantation. Methods: Between October 2011 and July 2016, 110 patients (mean age 73.3±7.6 years; 78 men) were treated with the Viabahn stent-graft for long SFA occlusions. Thirty-eight (34.5%) patients had DCB reinforcement at the distal edge of the stent-graft. For analysis, the population was divided into groups of no edge stenosis patients (n=88; mean lesion length 22.4±4.2 cm) and edge stenosis patients (n=22; mean lesion length 23.5±5.7 cm). The clinical outcomes, ankle-brachial indices, computed tomography angiography findings, and patency were compared at a minimum of 12 months. Logistic regression analysis was employed to determine risk factors for edge stenosis; the results are presented as the odds ratio (OR) and 95% confidence interval. Results: No differences in clinical or procedural characteristics were identified except the higher incidence of diabetes (p=0.008) and greater need for retrograde access (p=0.033) in the edge stenosis group. DCB reinforcement reduced the incidence of edge stenosis (p=0.021) and target lesion revascularization (TLR; p=0.010) and resulted in a significantly higher 1-year primary patency rate (92.1% vs 76.4%, p=0.042). However, multivariate analysis revealed only poor distal runoff (OR 0.31, 95% CI 0.11 to 0.83, p=0.020) as a predictor of edge stenosis. Conclusion: The risk of edge stenosis after Viabahn implantation was higher in patients with poor distal runoff. DCB reinforcement over the distal edge reduced edge stenosis, decreased 1-year TLR, and improved 1-year primary patency.

Original languageEnglish
Pages (from-to)313-319
Number of pages7
JournalJournal of Endovascular Therapy
Volume25
Issue number3
DOIs
Publication statusPublished - Jun 1 2018
Externally publishedYes

Fingerprint

Balloon Angioplasty
Femoral Artery
Statistical Factor Analysis
Pathologic Constriction
Pharmaceutical Preparations
Stents
Transplants
Odds Ratio
Protective Agents
Ankle Brachial Index
Incidence
Multivariate Analysis
Logistic Models
Regression Analysis
Confidence Intervals

Keywords

  • angioplasty
  • covered stent
  • drug-coated balloon
  • edge stenosis
  • occlusion
  • patency
  • peripheral artery disease
  • restenosis
  • runoff vessels
  • stent-graft
  • superficial femoral artery
  • target lesion revascularization

ASJC Scopus subject areas

  • Surgery
  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease : Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty. / Lin, Ting Chao; Huang, Chun Yang; Chen, Po Lin; Lee, Chiu Yang; Shih, Chun Che; Chen, I. Ming.

In: Journal of Endovascular Therapy, Vol. 25, No. 3, 01.06.2018, p. 313-319.

Research output: Contribution to journalArticle

@article{84d60d8fe4c74d688735c578771c6518,
title = "Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty",
abstract = "Purpose: To report a retrospective analysis of risk factors for edge restenosis after Viabahn stent-graft treatment of superficial femoral artery (SFA) occlusive disease and determine any protective effect of drug-coated balloons (DCBs) used at the time of stent-graft implantation. Methods: Between October 2011 and July 2016, 110 patients (mean age 73.3±7.6 years; 78 men) were treated with the Viabahn stent-graft for long SFA occlusions. Thirty-eight (34.5{\%}) patients had DCB reinforcement at the distal edge of the stent-graft. For analysis, the population was divided into groups of no edge stenosis patients (n=88; mean lesion length 22.4±4.2 cm) and edge stenosis patients (n=22; mean lesion length 23.5±5.7 cm). The clinical outcomes, ankle-brachial indices, computed tomography angiography findings, and patency were compared at a minimum of 12 months. Logistic regression analysis was employed to determine risk factors for edge stenosis; the results are presented as the odds ratio (OR) and 95{\%} confidence interval. Results: No differences in clinical or procedural characteristics were identified except the higher incidence of diabetes (p=0.008) and greater need for retrograde access (p=0.033) in the edge stenosis group. DCB reinforcement reduced the incidence of edge stenosis (p=0.021) and target lesion revascularization (TLR; p=0.010) and resulted in a significantly higher 1-year primary patency rate (92.1{\%} vs 76.4{\%}, p=0.042). However, multivariate analysis revealed only poor distal runoff (OR 0.31, 95{\%} CI 0.11 to 0.83, p=0.020) as a predictor of edge stenosis. Conclusion: The risk of edge stenosis after Viabahn implantation was higher in patients with poor distal runoff. DCB reinforcement over the distal edge reduced edge stenosis, decreased 1-year TLR, and improved 1-year primary patency.",
keywords = "angioplasty, covered stent, drug-coated balloon, edge stenosis, occlusion, patency, peripheral artery disease, restenosis, runoff vessels, stent-graft, superficial femoral artery, target lesion revascularization",
author = "Lin, {Ting Chao} and Huang, {Chun Yang} and Chen, {Po Lin} and Lee, {Chiu Yang} and Shih, {Chun Che} and Chen, {I. Ming}",
year = "2018",
month = "6",
day = "1",
doi = "10.1177/1526602818771345",
language = "English",
volume = "25",
pages = "313--319",
journal = "Journal of Endovascular Therapy",
issn = "1526-6028",
publisher = "International Society of Endovascular Specialists",
number = "3",

}

TY - JOUR

T1 - Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease

T2 - Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty

AU - Lin, Ting Chao

AU - Huang, Chun Yang

AU - Chen, Po Lin

AU - Lee, Chiu Yang

AU - Shih, Chun Che

AU - Chen, I. Ming

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Purpose: To report a retrospective analysis of risk factors for edge restenosis after Viabahn stent-graft treatment of superficial femoral artery (SFA) occlusive disease and determine any protective effect of drug-coated balloons (DCBs) used at the time of stent-graft implantation. Methods: Between October 2011 and July 2016, 110 patients (mean age 73.3±7.6 years; 78 men) were treated with the Viabahn stent-graft for long SFA occlusions. Thirty-eight (34.5%) patients had DCB reinforcement at the distal edge of the stent-graft. For analysis, the population was divided into groups of no edge stenosis patients (n=88; mean lesion length 22.4±4.2 cm) and edge stenosis patients (n=22; mean lesion length 23.5±5.7 cm). The clinical outcomes, ankle-brachial indices, computed tomography angiography findings, and patency were compared at a minimum of 12 months. Logistic regression analysis was employed to determine risk factors for edge stenosis; the results are presented as the odds ratio (OR) and 95% confidence interval. Results: No differences in clinical or procedural characteristics were identified except the higher incidence of diabetes (p=0.008) and greater need for retrograde access (p=0.033) in the edge stenosis group. DCB reinforcement reduced the incidence of edge stenosis (p=0.021) and target lesion revascularization (TLR; p=0.010) and resulted in a significantly higher 1-year primary patency rate (92.1% vs 76.4%, p=0.042). However, multivariate analysis revealed only poor distal runoff (OR 0.31, 95% CI 0.11 to 0.83, p=0.020) as a predictor of edge stenosis. Conclusion: The risk of edge stenosis after Viabahn implantation was higher in patients with poor distal runoff. DCB reinforcement over the distal edge reduced edge stenosis, decreased 1-year TLR, and improved 1-year primary patency.

AB - Purpose: To report a retrospective analysis of risk factors for edge restenosis after Viabahn stent-graft treatment of superficial femoral artery (SFA) occlusive disease and determine any protective effect of drug-coated balloons (DCBs) used at the time of stent-graft implantation. Methods: Between October 2011 and July 2016, 110 patients (mean age 73.3±7.6 years; 78 men) were treated with the Viabahn stent-graft for long SFA occlusions. Thirty-eight (34.5%) patients had DCB reinforcement at the distal edge of the stent-graft. For analysis, the population was divided into groups of no edge stenosis patients (n=88; mean lesion length 22.4±4.2 cm) and edge stenosis patients (n=22; mean lesion length 23.5±5.7 cm). The clinical outcomes, ankle-brachial indices, computed tomography angiography findings, and patency were compared at a minimum of 12 months. Logistic regression analysis was employed to determine risk factors for edge stenosis; the results are presented as the odds ratio (OR) and 95% confidence interval. Results: No differences in clinical or procedural characteristics were identified except the higher incidence of diabetes (p=0.008) and greater need for retrograde access (p=0.033) in the edge stenosis group. DCB reinforcement reduced the incidence of edge stenosis (p=0.021) and target lesion revascularization (TLR; p=0.010) and resulted in a significantly higher 1-year primary patency rate (92.1% vs 76.4%, p=0.042). However, multivariate analysis revealed only poor distal runoff (OR 0.31, 95% CI 0.11 to 0.83, p=0.020) as a predictor of edge stenosis. Conclusion: The risk of edge stenosis after Viabahn implantation was higher in patients with poor distal runoff. DCB reinforcement over the distal edge reduced edge stenosis, decreased 1-year TLR, and improved 1-year primary patency.

KW - angioplasty

KW - covered stent

KW - drug-coated balloon

KW - edge stenosis

KW - occlusion

KW - patency

KW - peripheral artery disease

KW - restenosis

KW - runoff vessels

KW - stent-graft

KW - superficial femoral artery

KW - target lesion revascularization

UR - http://www.scopus.com/inward/record.url?scp=85046792041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046792041&partnerID=8YFLogxK

U2 - 10.1177/1526602818771345

DO - 10.1177/1526602818771345

M3 - Article

C2 - 29673299

AN - SCOPUS:85046792041

VL - 25

SP - 313

EP - 319

JO - Journal of Endovascular Therapy

JF - Journal of Endovascular Therapy

SN - 1526-6028

IS - 3

ER -